Eagle Pharmaceuticals, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2016-11-23: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-11-16; Total offering amount $50,740,728.
- 2011-02-18: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2011-02-08; Total offering amount $18,522,295.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2016-11-23 | Rule 506(b) | Equity | 2016-11-16 | $50,740,728 | $2,740,728 | $48,000,000 | 2 |
| 2011-02-18 | Rule 506 | Equity | 2011-02-08 | $18,522,295 | $12,348,194 | $6,174,101 | 18 |